Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3 [Phase 2]
Phase 2 trial evaluating sofosbuvir with pegylated interferon and ribavirin for 12 weeks in treatment-experienced chronic hepatitis C genoty…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants [Phase 2]
Phase 2 trial update assessing ACH-0141625 or placebo with peginterferon and ribavirin in hepatitis C patients; safety, tolerability, and an…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders [Phase 2]
Phase 2 pilot trial evaluating the efficacy and tolerability of a quadruple therapy in HIV/hepatitis C coinfected patients who were nonrespo…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy. [Phase 2, Phase 3]
Phase 2/3 trial assessing low-dose pegylated interferon alfa-2b with ribavirin as maintenance therapy for chronic hepatitis C with liver fib…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of the monoclonal antibody CT-011 in patients with chronic hepatitis C infection (genotype I) has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C [Phase 1, Phase 2]
The study evaluated ribavirin monotherapy followed by combined ribavirin and hydroxychloroquine in hepatitis C, and the Phase 1/2 trial was …
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection [Phase 1, Phase 2]
Clinical trial update reporting antiviral efficacy, pharmacokinetics and safety data for BILN 2061 ZW in chronic hepatitis C from Phase 1/2 …
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C [Phase 2]
Phase 2 results for Boehringer Ingelheim's BILN-2061 ZW show antiviral activity, pharmacokinetics and safety data in patients with liver cir…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C [Phase 3]
Phase 3 trial comparing interferon alfacon-1 alone versus concomitant ribavirin dosing for hepatitis C; the study evaluated efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
A UCSF-sponsored clinical trial evaluating maternal Hepatitis C infection and influenza vaccination during pregnancy has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160) [Phase 3]
Phase 3 trial update assessing boceprevir in Russian participants with chronic hepatitis C genotype 1; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325 [Phase 1]
A Phase 1 drug-interaction study evaluated the effects of an oral contraceptive containing norethindrone acetate and ethinyl estradiol when …
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
This clinical trial update reports safety findings from a follow-up evaluation of participants in a Phase 1 study of BMS-986094 (INX-08189),…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV [Phase 1]
Phase 1 study evaluating the effects of anti-HIV drugs on hepatitis C virus in adults co-infected with HIV and hepatitis C; the trial status…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
A completed clinical trial studying gut-associated lymphocytes in HIV and HIV/Hepatitis C co-infected individuals, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV) [Phase 2]
Phase 2 trial evaluating antiviral activity, safety, tolerability and pharmacokinetics of TMC435350 in participants with hepatitis C; study …
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation [EARLY_Phase 1]
An early-phase (Phase 1) pilot study evaluated peginterferon, ribavirin, and boceprevir given before liver transplantation to clear hepatiti…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin [Phase 1]
A Phase 1 trial evaluated the drug interaction between a daclatasvir/asunaprevir/BMS-791325 combination and rosuvastatin in Hepatitis C pati…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4 [Phase 3]
This entry documents a Phase 3 trial evaluating high-dose ribavirin for chronic hepatitis C genotype 1 or 4, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet [Phase 1]
Completed Phase 1 pharmacokinetic study evaluating the impact of renal impairment on blood levels of a fixed-dose combination tablet contain…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Pirfenidone, an Antifibrotic and Antiinflammatory Drug [Phase 2]
Phase 2 trial of pirfenidone, an antifibrotic and anti-inflammatory drug, has completed evaluating its effects in fibrosis and chronic hepat…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection [Phase 2]
Phase 2 trial evaluating adding TCM-700C to standard treatment for genotype 1 chronic hepatitis C. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C [Phase 2]
Phase 2 study evaluating VX-222 in combination with telaprevir and ribavirin for genotype 1a chronic hepatitis C in treatment-naive patients…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Absolute Bioavailability of BMS-791325 [Phase 1]
Phase 1 trial reporting the absolute bioavailability of the investigational hepatitis C drug BMS-791325.
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV [Phase 2]
Phase 2 clinical trial update evaluating safety, tolerability, pharmacokinetics, and activity of GS-9450 in subjects with chronic hepatitis …